{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T08:37:56Z","timestamp":1782549476632,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32102848"],"award-info":[{"award-number":["32102848"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["KQTD20200820151701004"],"award-info":[{"award-number":["KQTD20200820151701004"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFF0702200"],"award-info":[{"award-number":["2021YFF0702200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFF0702204"],"award-info":[{"award-number":["2021YFF0702204"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.biopha.2023.115968","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:25:43Z","timestamp":1701390343000},"page":"115968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Protective effect of novel angiotensin receptor neprilysin inhibitor S086 on target organ injury in spontaneously hypertensive rats"],"prefix":"10.1016","volume":"170","author":[{"given":"Ying","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Suo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9995","key":"10.1016\/j.biopha.2023.115968_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(14)61468-9","article-title":"Hypertension","volume":"386","author":"Poulter","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2023.115968_bib2","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-016-0642-9","article-title":"Hypertension, blood pressure variability, and target organ lesion","volume":"18","author":"Irigoyen","year":"2016","journal-title":"Curr. Hypertens. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2023.115968_bib3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.pcl.2022.07.005","article-title":"Hypertension in children and young adults","volume":"69","author":"Haseler","year":"2022","journal-title":"Pediatr. Clin. North Am."},{"issue":"11","key":"10.1016\/j.biopha.2023.115968_bib4","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2018.07.008","article-title":"Prevention and control of hypertension: JACC health promotion series","volume":"72","author":"Carey","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115968_bib5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0000000000000881","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.biopha.2023.115968_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.hfc.2019.09.001","article-title":"Hypertension and heart failure: prevention, targets, and treatment","volume":"16","author":"Di Palo","year":"2020","journal-title":"Heart Fail. Clin."},{"issue":"4, Supplement","key":"10.1016\/j.biopha.2023.115968_bib7","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jash.2014.03.064","volume":"8","author":"Kizilirmak","year":"2014","journal-title":"J. Am. Soc. Hypertens."},{"issue":"5","key":"10.1016\/j.biopha.2023.115968_bib8","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ijcard.2012.10.007","article-title":"The past, present and future of renin\u2013angiotensin aldosterone system inhibition","volume":"167","author":"Mentz","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2023.115968_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijcard.2016.06.083","article-title":"Angiotensin receptor\u2013neprilysin inhibitor (ARNi): Clinical studies on a new class of drugs","volume":"226","author":"Gori","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115968_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrcardio.2016.200","article-title":"Long-term neprilysin inhibition \u2014 implications for ARNIs","volume":"14","author":"Campbell","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115968_bib11","first-page":"683","article-title":"The renin-angiotensin system in hypertension, a constantly renewing classic: focus on the angiotensin AT2-receptor","volume":"36","author":"Assersen","year":"2020","journal-title":"Can. J. Cardiol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115968_bib12","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1001\/jamacardio.2018.3957","volume":"3","author":"Srivastava","year":"2018","journal-title":"JAMA Cardiol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115968_bib13","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1021\/jm00010a014","article-title":"Dicarboxylic acid dipeptide neutral endopeptidase inhibitors","volume":"38","author":"Ksander","year":"1995","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2023.115968_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004872-199302000-00007","article-title":"EXP3174, a metabolite of losartan (MK 954, DuP 753) is more potent than losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells","volume":"11","author":"Sachinidis","year":"1993","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2023.115968_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110410","article-title":"Pharmacodynamic and pharmacokinetic effects of S086, a novel angiotensin receptor neprilysin inhibitor","volume":"129","author":"Sun","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.biopha.2023.115968_bib16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/13543784.2021.1985464","volume":"31","author":"Hu","year":"2022","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"8","key":"10.1016\/j.biopha.2023.115968_bib17","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/s41440-023-01326-7","article-title":"Efficacy and safety of sacubitril\/allisartan for the treatment of primary hypertension: a phase 2 randomized, double-blind study","volume":"46","author":"Zhang","year":"2023","journal-title":"Hypertens. Res."},{"issue":"2","key":"10.1016\/j.biopha.2023.115968_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cardiores.2004.04.013","article-title":"Transmural changes in size, contractile and electrical properties of SHR left ventricular myocytes during compensated hypertrophy","volume":"63","author":"McCrossan","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115968_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0008-6363(98)00076-5","article-title":"Rat models of hypertension, cardiac hypertrophy and failure","volume":"39","author":"Doggrell","year":"1998","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.biopha.2023.115968_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/1074248419838503","article-title":"AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan","volume":"24","author":"Zhao","year":"2019","journal-title":"J. Cardiovasc Pharm. Ther."},{"key":"10.1016\/j.biopha.2023.115968_bib21","first-page":"162","article-title":"LCZ696 reduces myocardial fibrosis in hypertensive rats in the setting of heart failure","volume":"112","author":"Trivedi","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115968_bib22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cardfail.2017.12.010","article-title":"LCZ696 (Sacubitril\/Valsartan), an angiotensin-receptor neprilysin inhibitor, attenuates cardiac hypertrophy, fibrosis, and vasculopathy in a rat model of chronic kidney disease","volume":"24","author":"Suematsu","year":"2018","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.biopha.2023.115968_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejphar.2015.05.059","article-title":"Pre-treatment with LCZ696, an orally active angiotensin receptor neprilysin inhibitor, prevents ischemic brain damage","volume":"762","author":"Bai","year":"2015","journal-title":"Eur. J. Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2023.115968_bib24","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/ajh\/hpv015","article-title":"LCZ696, Angiotensin II Receptor-Neprilysin Inhibitor, Ameliorates High-Salt-Induced Hypertension and Cardiovascular Injury More Than Valsartan Alone","volume":"28","author":"Kusaka","year":"2015","journal-title":"Am. J. Hypertens."},{"issue":"5","key":"10.1016\/j.biopha.2023.115968_bib25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.5603\/CJ.a2018.0048","article-title":"Effect of LCZ696, a dual angiotensin receptor neprilysin inhibitor, on isoproterenol-induced cardiac hypertrophy, fibrosis, and hemodynamic change in rats","volume":"26","author":"Miyoshi","year":"2019","journal-title":"Cardiol. J."},{"key":"10.1016\/j.biopha.2023.115968_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120850","article-title":"LCZ696 (sacubitril\/valsartan) protects against cyclophosphamide-induced nephrotoxicity in adult male rats: Up-regulation of Apelin-13\/ACE2, miR-200, and down-regulation of TGF-\u03b2\/SMAD 2\/3 and miR-192","volume":"306","author":"Abbas","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.115968_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119692","article-title":"Renal protective effects and mechanisms of the angiotensin receptor-neprilysin inhibitor LCZ696 in mice with cardiorenal syndrome","volume":"280","author":"Li","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.115968_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115684","article-title":"MMP-2 and its implications on cardiac function and structure: Interplay with inflammation in hypertension","volume":"215","author":"Ribeiro Vitorino","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115968_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrcardio.2014.64","article-title":"Natriuretic peptides in cardiometabolic regulation and disease","volume":"11","author":"Zois","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115968_bib30","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/ATVBAHA.118.311229","article-title":"Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension","volume":"38","author":"Brown","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115968_bib31","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1053\/j.ajkd.2012.07.029","article-title":"Pulmonary Hypertension in CKD","volume":"61","author":"Bolignano","year":"2013","journal-title":"Am. J. Kidney Dis."},{"issue":"7","key":"10.1016\/j.biopha.2023.115968_bib32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jash.2017.04.012","article-title":"Pharmacokinetic, pharmacodynamic, and antihypertensive effects of the neprilysin inhibitor LCZ-696: sacubitril\/valsartan","volume":"11","author":"Chrysant","year":"2017","journal-title":"J. Am. Soc. Hypertens."},{"issue":"4","key":"10.1016\/j.biopha.2023.115968_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.336","article-title":"Prevention against renal damage in rats with subtotal nephrectomy by sacubitril\/valsartan (LCZ696), a dual-acting angiotensin receptor-neprilysin inhibitor","volume":"5","author":"Ushijima","year":"2017","journal-title":"Pharm. Res Perspect."},{"issue":"4","key":"10.1016\/j.biopha.2023.115968_bib34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/jcbfm.2009.246","article-title":"Hypertension-induced vascular remodeling contributes to reduced cerebral perfusion and the development of spontaneous stroke in aged SHRSP rats","volume":"30","author":"Henning","year":"2010","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"6","key":"10.1016\/j.biopha.2023.115968_bib35","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.051","article-title":"Telmisartan reduces progressive oxidative stress and phosphorylated \u03b1-synuclein accumulation in stroke-resistant spontaneously hypertensive rats after transient middle cerebral artery occlusion","volume":"23","author":"Sato","year":"2014","journal-title":"J. Stroke Cereb. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2023.115968_bib36","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.02.019","article-title":"Telmisartan ameliorates inflammatory responses in SHR-SR after tMCAO","volume":"23","author":"Sato","year":"2014","journal-title":"J. Stroke Cereb. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2023.115968_bib37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1179\/1743132815Y.0000000002","article-title":"Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats","volume":"37","author":"Liu","year":"2015","journal-title":"Neurol. Res"},{"issue":"9","key":"10.1016\/j.biopha.2023.115968_bib38","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1097\/HJH.0000000000001762","article-title":"Effects of dual angiotensin type 1 receptor\/neprilysin inhibition vs. angiotensin type 1 receptor inhibition on target organ injury in the stroke-prone spontaneously hypertensive rat","volume":"36","author":"Rubattu","year":"2018","journal-title":"J. Hypertens."},{"issue":"7","key":"10.1016\/j.biopha.2023.115968_bib39","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/0192623320951154","article-title":"Proliferative and Nonproliferative Lesions of the Rat and Mouse Central and Peripheral Nervous Systems: New and Revised INHAND Terms","volume":"48","author":"Bradley","year":"2020","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.biopha.2023.115968_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175754","article-title":"Sacubitril\/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats","volume":"952","author":"Li","year":"2023","journal-title":"Eur. J. Pharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223017663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223017663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:46:48Z","timestamp":1773967608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223017663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"alternative-id":["S0753332223017663"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115968","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of novel angiotensin receptor neprilysin inhibitor S086 on target organ injury in spontaneously hypertensive rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115968"}}